AnGes, Inc.
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
4563 | T
Overview
Corporate Details
- ISIN(s):
- JP3127700007
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ七丁目７番１５号
- Website:
- https://www.anges.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AnGes, Inc., founded in 1999, is a biopharmaceutical company dedicated to the research and development of gene-based medicines. The company focuses on becoming a global leader in genetic pharmaceuticals by developing innovative treatments that harness the power of genes. Its core pipeline includes Hepatocyte Growth Factor (HGF) gene therapy products for blood vessel regeneration, DNA vaccines based on plasmid DNA technology, and NF-kB decoy oligonucleotides. AnGes actively engages in clinical studies and forms global alliances and manufacturing collaborations to advance its therapeutic programs and make novel treatments accessible to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-07 07:30 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 244.5 KB | ||
| 2025-08-13 06:50 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2025-08-13 04:19 |
Interim Report
半期報告書－第27期(2025/01/01－2025/12/31)
|
Japanese | 488.0 KB | ||
| 2025-03-31 04:52 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 25.5 KB | ||
| 2025-03-31 03:22 |
Governance Information
内部統制報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 23.7 KB | ||
| 2025-03-31 03:18 |
Registration Form
確認書
|
Japanese | 8.9 KB | ||
| 2025-03-31 03:17 |
Registration Form
有価証券報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 1.5 MB | ||
| 2024-09-03 06:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 203.2 KB | ||
| 2024-08-30 09:06 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 381.2 KB | ||
| 2024-08-14 02:28 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2024-08-14 02:27 |
Interim Report
半期報告書－第26期(2024/01/01－2024/12/31)
|
Japanese | 725.7 KB | ||
| 2024-05-14 02:27 |
Report Publication Announcement
確認書
|
Japanese | 8.9 KB | ||
| 2024-05-14 02:25 |
Quarterly Report
四半期報告書－第26期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 457.7 KB | ||
| 2024-03-29 01:45 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 24.0 KB | ||
| 2024-03-29 01:43 |
Governance Information
内部統制報告書－第25期(2023/01/01－2023/12/31)
|
Japanese | 23.6 KB |
Automate Your Workflow. Get a real-time feed of all AnGes, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AnGes, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AnGes, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
